Vir Biotechnology Inc (VIR)

09:29 AM

Vir Biotechnology Begins Phase 1 Trial for VIR-5525 - TipRanks

09:29 AM

08:18 AM

Vir Biotechnology doses first patient in EGFR-targeted cancer trial By Investing.com - Investing.com South Africa

08:18 AM

08:05 AM

Vir Biotechnology Announces First Patient Dosed in Phase 1 Clinical Trial of EGFR-Targeting PRO-XTEN™ Dual-Masked T-Cell Engager VIR-5525 for the Treatment of Solid Tumors - Yahoo Finance

08:05 AM

Jul 23, 2025

Vir Biotechnology Inc. Stock Analysis and ForecastExceptional return forecasts - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What drives Vir Biotechnology Inc. stock priceUnstoppable investment returns - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Vir Biotechnology: Hep B And Cancer Projects March On (NASDAQ:VIR) - Seeking Alpha

Jul 23, 2025

Jul 23, 2025

Have Insiders Sold Vir Biotechnology Shares Recently? - simplywall.st

Jul 23, 2025

Jul 22, 2025

What analysts say about Vir Biotechnology Inc. stockRapidly expanding wealth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Vir Biotechnology to Provide Corporate Update and Report Second Quarter 2025 Financial Results on August 6, 2025 - Business Wire

Jul 22, 2025

Jul 22, 2025

Is Vir Biotechnology Inc. a good long term investmentSuperior investment outcomes - jammulinksnews.com

Jul 22, 2025

Jul 19, 2025

(VIR) Investment Analysis and Advice - news.stocktradersdaily.com

Jul 19, 2025

Jul 17, 2025

Vir Biotechnology EVP Eisner sells $57k in stock By Investing.com - Investing.com Canada

Jul 17, 2025

Jul 15, 2025

Biotech IPO For The Week Ahead - RTTNews

Jul 15, 2025

Jul 11, 2025

Raymond James Initiates Vir Biotechnology(VIR.US) With Buy Rating, Announces Target Price $12 - 富途牛牛

Jul 11, 2025

Jul 11, 2025

Where Vir Biotechnology Stands With Analysts - Benzinga

Jul 11, 2025

Jul 11, 2025

Raymond James Initiates Vir Biotechnology at Outperform With $12 Price Target - MarketScreener

Jul 11, 2025

Jul 10, 2025

Vir Biotechnology (VIR) Soars 11.9%: Is Further Upside Left in the Stock? - Yahoo Finance

Jul 10, 2025

Jul 09, 2025

Unraveling Vir Biotechnology's 10.6% Spike: A Technical Deep Dive - AInvest

Jul 09, 2025

Jul 09, 2025

Unraveling Vir Biotechnology's 8.8% Surge: A Deep Dive - AInvest

Jul 09, 2025

Jul 08, 2025

How to Take Advantage of moves in (VIR) - news.stocktradersdaily.com

Jul 08, 2025

Jul 07, 2025

Vir Biotechnology Insiders Sell US$1.1m Of Stock, Possibly Signalling Caution - simplywall.st

Jul 07, 2025

Jul 02, 2025

Hepatitis D Pipeline Appears Robust With 8+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail

Jul 02, 2025

Jun 25, 2025

Is Vir Biotechnology (NASDAQ:VIR) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Jun 25, 2025

Jun 17, 2025

Long Term Trading Analysis for (VIR) - news.stocktradersdaily.com

Jun 17, 2025

Jun 10, 2025

Transcript : Vir Biotechnology, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 04 - MarketScreener

Jun 10, 2025

Jun 05, 2025

(VIR) Trading Advice - news.stocktradersdaily.com

Jun 05, 2025

Jun 03, 2025

Vir Biotechnology director Janet Napolitano sells $16,148 in stock - Investing.com Australia

Jun 03, 2025

Jun 03, 2025

Vir Biotechnology director Janet Napolitano sells $16,148 in stock By Investing.com - Investing.com UK

Jun 03, 2025

May 29, 2025

Vir Biotechnology Holds 2025 Annual Stockholder Meeting - TipRanks

May 29, 2025

May 29, 2025

Vir Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025 - BioSpace

May 29, 2025

May 28, 2025

Vir Biotechnology to Participate in the Goldman Sachs 46th Annua - GuruFocus

May 28, 2025

May 28, 2025

Vir Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025 | VIR Stock News - GuruFocus

May 28, 2025

May 27, 2025

Vir Biotech at TD Cowen’s Summit: Strategic Focus on HDV and Oncology - Investing.com

May 27, 2025

May 26, 2025

Gilead Ready To Go After Hepatitis D Again - insights.citeline.com

May 26, 2025

May 22, 2025

Vir Biotechnology Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) - Benzinga

May 22, 2025